CLBK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CLBK is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to allocate. The stock has a constructive short-term technical setup and solid Q1 financial growth, but analyst sentiment has turned neutral, there is no fresh news catalyst, and the option market is strongly bullish but not enough to override the lack of a clear buy signal from Intellectia signals. If the investor is impatient and wants to enter now, this is more of a hold than an immediate buy.
CLBK is in a short-term uptrend: SMA 5 > SMA 20 > SMA 200, which is bullish. MACD histogram is positive at 0.0637, though contracting, suggesting momentum remains positive but is fading somewhat. RSI_6 at 67.5 is near overbought but not extreme. Price at 19.30 is just below the first resistance at 19.573 and above the pivot at 18.912, indicating the stock is trading near the upper end of its recent range. Overall, the trend is bullish, but the setup is not ideal for a fresh aggressive long-term entry at this exact level.
["Q1 2026 revenue rose 16.78% YoY.", "Q1 2026 net income rose 47.18% YoY.", "Q1 2026 EPS rose 44.44% YoY.", "Bullish moving average structure supports ongoing upward trend.", "Options positioning is strongly bullish with very low put-call ratios.", "Piper Sandler noted the Northfield Bancorp acquisition could improve profitability and growth through synergies."]
["No news in the recent week, so there is no clear event-driven catalyst.", "Analyst sentiment has softened to Neutral, including a downgrade from Buy by Brean Capital.", "Piper Sandler initiated coverage with only a Neutral rating and $18 target.", "MACD momentum is positive but contracting, which can signal slowing upside.", "Price is approaching resistance near 19.573, limiting immediate upside from current levels."]
Latest quarter: 2026/Q1. Financial performance was strong, with revenue up 16.78% YoY to 68.3 million, net income up 47.18% YoY to 13.1 million, and EPS up 44.44% YoY to 0.13. This shows clear earnings and revenue growth, which is favorable for a long-term view. Gross margin was flat at 0, so the key improvement came from bottom-line expansion rather than margin growth.
Recent analyst trend is neutral-to-cautious. On 2026-03-16, Piper Sandler initiated coverage with a Neutral rating and $18 price target, citing weaker profitability versus peers but acknowledging strategic benefits from the Northfield Bancorp acquisition. On 2026-03-12, Brean Capital downgraded CLBK to Neutral from Buy with a $19 target. Wall Street’s pros are acquisition synergies, geographic overlap benefits, and improving profitability potential. The cons are below-peer profitability and the fact that the stock already trades around 1.7x TBV, limiting easy upside.
